NCT07568743 ProVu Video Stylet With Versus Without the Fekry Airway
| NCT ID | NCT07568743 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Endotracheal Intubation |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2026-05-10 |
| Primary Completion | 2026-09-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 130 participants in total. It began in 2026-05-10 with a primary completion date of 2026-09-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aimed to compare assisted intubation using the ProVu video stylet device passing through Fekry airway versus intubation without the use of Fekry airway . The investigators hypothesized that endotracheal intubation assisted by ProVu video stylet using the Fekry airway as a conduit for intubation would improve the glottic visualization and the higher first attempt success rate when compared to endotracheal intubation assisted by ProVu video stylet without using the Fekry airway.
Eligibility Criteria
Inclusion Criteria: * • American Society of Anesthesiologists (ASA) physical status I, II. * Patients scheduled for elective surgery requiring general anesthesia and orotracheal intubation of less than 2 hours duration . * Ganzouri Airway score \<3. Exclusion Criteria: * Patient with Active cardiac condition. * Patient with airway congenital anomaly. * Mallampati score III or IV. * Body mass index (BMI) \> 35 kg/m² (obesity). * Limited cervical spine mobility. * History of difficult intubation, upper airway surgery, or trauma. * Facial or oropharyngeal deformities. * Allergy or contraindication to study medications. * Refusal to participate.
Contact & Investigator
Reham Ali Abdelrahman
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT07568743 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Endotracheal Intubation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07568743 currently recruiting?
Yes, NCT07568743 is actively recruiting participants. Contact the research team at rehamali72@hotmail.com for enrollment information.
Where is the NCT07568743 trial being conducted?
This trial is being conducted at Cairo, Egypt, Cairo, Egypt.
Who is sponsoring the NCT07568743 clinical trial?
NCT07568743 is sponsored by Cairo University. The principal investigator is Reham Ali Abdelrahman at Cairo University. The trial plans to enroll 130 participants.